Amneal Pharmaceuticals Revenue and Competitors

Bridgewater, NJ USA

Location

$854M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Amneal Pharmaceuticals's estimated annual revenue is currently $2.1B per year.(i)
  • Amneal Pharmaceuticals's estimated revenue per employee is $367,804
  • Amneal Pharmaceuticals's total funding is $854M.

Employee Data

  • Amneal Pharmaceuticals has 5628 Employees.(i)
  • Amneal Pharmaceuticals grew their employee count by 8% last year.

Amneal Pharmaceuticals's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
President & Co-CEOReveal Email/Phone
3
EVP, Chief Human Resources OfficerReveal Email/Phone
4
Executive Assistant To Co-Chairman and FounderReveal Email/Phone
5
Assistant To SVP, Chief Commercial Officer-Specialty and SVP, Global BDReveal Email/Phone
6
Production OfficerReveal Email/Phone
7
Senior OfficerReveal Email/Phone
8
Trainee officerReveal Email/Phone
9
VP, Global Regulatory AffairsReveal Email/Phone
10
VP, R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Amneal Pharmaceuticals?

Privately owned and operated since 2001, Amneal is a growth-oriented company dedicated to developing and manufacturing the finest quality generic prescription drugs. We welcome you to tour our site and discover the many facets of our company.

keywords:N/A

$854M

Total Funding

5628

Number of Employees

$2.1B

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Amneal Pharmaceuticals News

2022-04-20 - Amneal secures second US biosimilars approval

Last week saw the US Food and Drug Administration (FDA) approve the Biologics License Application (BLA) from Amneal Pharmaceuticals Inc for...

2022-04-17 - FDA Approves Alymsys® (bevacizumab-maly), a Biosimilar of ...

"The entire Brand Institute and Drug Safety Institute Team congratulates Amneal Pharmaceuticals and mAbxience on the FDA approval of ALYMSYS,"...

2022-03-30 - Almirall, LLC v. Amneal Pharmaceuticals LLC (Fed. Cir. 2022 ...

Amneal Pharmaceuticals LLC. The case arose in an inter partes review (IPR) proceeding by challenger Amneal over Almirall's U.S. Patent No.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1603.5M6363N/AN/A
#2
$1589.1M790613%N/A
#3
$2643.3M105315%N/A
#4
$3172.4M126396%N/A
#5
$38500M1254472%N/A